Study reveals the molecular origin of the genetic disease cystinosis
New understanding of how the transporter protein cystinosin functions may lead to better treatments for a devastating genetic disease.
New understanding of how the transporter protein cystinosin functions may lead to better treatments for a devastating genetic disease.
UCSC scientists reported three crystal structures of periodic rippled beta sheets, a novel protein structure with potential applications in biomedicine and materials science.
Laura Sanchez, associate professor of chemistry and biochemistry at UCSC, has been chosen to receive the 2022 ACS Infectious Diseases Young Investigator Award.
Kimmey’s lab is investigating how susceptibility to infections is influenced by the daily biological cycles known as circadian rhythms.
With the new award, IBSC directors have now brought in nearly $12 million to fund the future of bimolecular research at UCSC.
UC Santa Cruz has joined the University of California Drug Discovery Consortium (UC DDC), a cross-campus initiative aimed at building a drug discovery community that actively promotes research translation through industry partnerships.
New funding will advance research on how effects of environmental stresses can be transmitted from one generation to the next.
A team of scientists has reconstituted the circadian clock of cyanobacteria in a test tube, enabling them to study rhythmic interactions of the clock proteins in real time and understand how these interactions enable the clock to exert control over gene expression.
A $4.9 million grant from the California Institute for Regenerative Medicine supports a pre- and postdoctoral training program in systems biology of stem cells at UCSC
The NIH Centers of Excellence in Genomic Science program has awarded $13.5 million over five years for a new center to advance genomics in biomedical research
One-year, $3 million contract with the California Department of Public Health will galvanize pandemic-related genomic data analysis efforts for the public good
Scientists at UC Santa Cruz, UC Berkeley, and Stanford are working together to discover and treat the causes behind age-associated cognitive decline.